Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 41 (RBM41) is a protein encoded by the RBM41 gene in humans and is predicted to have U12 snRNA binding activity and pre-mRNA intronic binding activity[1][3][5][7][8]. It is involved in mRNA splicing via the spliceosome, likely as a part of the U12-type spliceosomal complex[1][3][5][7][8]. RBM41 belongs to the broad family of RNA-binding proteins, many of which regulate diverse RNA processing functions through specific RNA–protein interactions, but there is limited evidence for RBM41 as a therapeutic target or its direct involvement in disease, and no drugs are currently known to interact with it[1][3][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 41 (RBM41).